Click Therapeutics' digital therapeutic (DTx) CT-132 has been approved by the FDA, becoming the first treatment of its type ...

Download our guide to the digital therapeutics landscape, key providers, and market trends. Discover how digital health solutions can enhance pharmaceutical outcomes.

APPS's bull thesis hinges on stabilizing ODS and growing the advertisement segment, leveraging high gross margins in DTX despite lower R&D investments. APPS's shift from waterfall to SDK bidding ...

Emerging technologies not only expedite the development of new drugs, but also introduce a completely new class of therapies, such as digital therapeutics (DTx), which are software-based solutions ...

Kyorin Pharma has signed a deal with digital health firm Hyfe to develop a digital therapeutic (DTx) for people with chronic cough and launch it in Japan. Hyfe's platform uses artificial ...

Co-led by Lakhani and Assistant Professor Iavor Bojinov, the creation of the AI-native course was supported through the collaboration of Digital Transformation (DTx), the Digital Data Design Institute ...

The Global Digital Therapeutics Market is valued at USD 7.95 Billion in 2024 and is projected to reach a value of USD 75.71 ...

DTx Pharma’s next-generation, fatty acid ligand-conjugated oligonucleotides enable efficient delivery of RNA-based therapeutics to cells and tissues throughout the body. With three disease ...

This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products ...